Othman Al-Sawaf

30PUBLICATIONS
66CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer cell biologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 27, 2026
Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.

|Apr 14, 2026
Transition Into Clinical Routine and Survival Outcomes of BCL2- and BTK Inhibitors: An Analysis of Patient Data From the GCLLSG Registry.

Nadine Kutsch, Rudy Ligtvoet, Sandra Robrecht

|Jan 13, 2026
The landscape and evolution of clonal hematopoiesis in chronic lymphocytic leukemia.

Othman Al-Sawaf, Benjamin N Locher, Friederike Christen

|Dec 08, 2025
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia.

Othman Al-Sawaf, Janina Stumpf, Can Zhang

|Aug 27, 2025
The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL.

Othman Al-Sawaf, Moritz Fürstenau, Adam Giza

|Dec 10, 2024
Surrogate endpoints in mature B-cell neoplasms - meaningful or misleading?

Florian Simon, Othman Al-Sawaf, John F Seymour

Pageof 5

Frequent Collaborators

7 joint publications

Florian Simon

6 joint publications

Moritz Fürstenau

6 joint publications

Michael J Hallek

6 joint publications

Carsten Utoft Niemann